TRCT
ONCY

Tower Research Capital (TRC)’s Oncolytics Biotech ONCY Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,717
Closed -$4.24K – 5485
2025
Q1 		$4.24K Buy
+7,717
New +$5.64K ﹤0.01% 4284
2024
Q4 		– Sell
-2,017
Closed -$1.78K – 5914
2024
Q3 		$1.78K Sell
2,017
-1,222
-38% -$1.2K ﹤0.01% 5104
2024
Q2 		$3.19K Buy
+3,239
New +$3.53K ﹤0.01% 4923
2024
Q1 		– Sell
-17
Closed -$23 – 6063
2023
Q4 		$23 Buy
+17
New +$27 ﹤0.01% 5813
2023
Q3 		– Sell
-2,639
Closed -$6.86K – 6153
2023
Q2 		$6.86K Sell
2,639
-13,378
-84% -$22.2K ﹤0.01% 4651
2023
Q1 		$19K Buy
16,017
+10,402
+185% +$16.3K ﹤0.01% 3499
2022
Q4 		$9K Buy
5,615
+1,802
+47% +$2.74K ﹤0.01% 4233
2022
Q3 		$5K Sell
3,813
-2,409
-39% -$2.95K ﹤0.01% 5158
2022
Q2 		$6K Buy
6,222
+5,275
+557% +$6.41K ﹤0.01% 4939
2022
Q1 		$2K Sell
947
-767
-45% -$1.29K ﹤0.01% 5580
2021
Q4 		$3K Buy
+1,714
New +$3.17K ﹤0.01% 5473
2021
Q3 		– Sell
-2,160
Closed -$6K – 6044
2021
Q2 		$6K Buy
+2,160
New +$6.62K ﹤0.01% 4635
2020
Q4 		– Sell
-60
Closed – – 5336
2020
Q3 		$0 Buy
+60
New +$110 ﹤0.01% 5017

Other funds holding ONCY

SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HL
HeadInvest LLC Portland, Maine $488M AUM 14.33% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Tower Research Capital (TRC)'s ONCY Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Oncolytics Biotech (ONCY) in Q2 2025, closing a stake of 7,717 shares — an estimated $4.24K sold.

Tower Research Capital (TRC) first reported a position in ONCY in Q3 2020 and held it in 13 quarters. The position peaked at $19K in Q1 2023. 55 funds tracked by Wall St. Rank hold ONCY as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining Oncolytics Biotech position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,717 Oncolytics Biotech shares in Q2 2025, an estimated $4.24K.
  • Tower Research Capital (TRC) first reported a position in Oncolytics Biotech in Q3 2020 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Oncolytics Biotech position peaked at $19K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.